Mauro Mileni
Principal investigator, leads ABILITA BIO, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.9MFederal grants as PI5 awards
4Patents grantedLatest Jul 8, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 15, 2023 | NIH | SBIR Phase I Novel Anti-CCR8 VHH for the Treatment of NSCLC | $399K | ABILITA BIO, INC. |
| Sep 15, 2021 | NIH | SBIR Phase I Discovery of Novel Blood-Brain Barrier Targeting Antibodies for the Treatment of Alzheimer's Disease | $433K | ABILITA BIO, INC. |
| Sep 1, 2019 | NIH | SBIR Phase I Discovery of therapeutic nanobodies targeting the G protein-coupled receptors in the brain for the treatment of Alzheimer Disease | $415K | ABILITA BIO, INC. |
| Jul 1, 2018 | NIH | SBIR Phase I Development of highly selective therapeutics targeting NaV channel subtypes for the non-opioid treatment of pain | $311K | ABILITA BIO, INC. |
| Sep 19, 2016 | NIH | SBIR Phase I Discovery of therapeutic antibodies targeting breast cancer metastasis using Enabled G-Protein-Coupled Receptors | $300K | ABILITA BIO, INC. |
5 patents as inventor
- US 10287349ABILITA BIO, INC.May 14, 2019
- US 10845367ABILITA BIO, INC.Nov 24, 2020
- US 11053312ABILITA BIO, INC.Jul 6, 2021
- US 12351628ABILITA BIO, INC.Jul 8, 2025
- US ABILITA BIO, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,142
Awards as PI#417
Patents#41
Companies
- ABILITA BIO, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.